Advertisement

Topics

Companies Related to "ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution" [Most Relevant Company Matches] RSS

15:35 EDT 19th October 2018 | BioPortfolio

Here are the most relevant search results for "ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution" found in our extensive corporate database of over 50,000 company records.

Showing "Study Curative Treatment Osteoradionecrosis With Hybrid Bone Substitution" Companies 1–25 of 4,000+

Relevant

Velcura Therapeutics, Inc

Velcura Therapeutics™, Inc. is a leading biotechnology firm in the treatment of bone-related injuries and bone disorders. Velcura develops therapies directed at stimulating bone formation. Velcura can grow human bone outside the body (ex vivo) using a rapid (3 – 5 days) and reliable method. We apply molecular and biological bone assays to the systematic discovery of the genes, biological pathw...


Essentys AB

Essentys AB is an innovative biotech company developing therapeutics for the treatment and prevention of diseases in the elderly.The Company is currently focused on the development of its lead product ES 1 in osteoporosis, in which proof of concept has been obtained in clinical phase II studies. ES 1 constitutes a completely new approach to the treatment and prevention of osteoporosis. The data su...

Magenta Therapeutics Inc.

Magenta Therapeutics is a biotechnology company developing therapeutics to revolutionize bone marrow transplant for patients with autoimmune diseases, blood cancers and genetic diseases. By creating a platform focused on critical areas of transplant medicine, Magenta Therapeutics is pioneering an integrated approach to extend the curative power of bone mar...


Curative Health Services

Curative Health Services, a publicly traded company delivers superior clinical outcomes and patient satisfaction levels, while achieving measurable financial performance for our partners.Our Specialty Healthcare Services (SHS) business unit is a leader in wound care management. Curative's complete Wound Management ProgramSM is designed to treat the patient, not just the wound, through a continuum ...

Immunodiagnostic Systems Ltd. (IDS Ltd.)

SBA Sciences is a Finnish company developing novel immunoassays for bone metabolism studies and diagnostics.BoneTRAP® kit has been developed for detection of bone metastasis and follow up of osteoporosis treatment.

Bone Solutions Inc.

BSI (www.bonesolutionsinc.com) intends to establish its magnesium-based platform as the ‘one stop bone-, tendon- and ligament-injectable, biodegradable adhesive technology’ for surgeries at hospitals, clinics and other private surgical centers within the orthopedic industry. The Company believes its FDA-certified bone void filler, OsteoCreteâ„...

SI-BONE, Inc.

SI-BONE, Inc. (Cupertino, California) is a leading spinal medical device company dedicated to the development of tools and products for diagnosing and treating patients with low back issues related to sacroiliac (SI) joint pathology. The company has developed, and is manufacturing and marketing, less invasive approaches using implants for the treatment of SI Joint pathology. SI-BONE has an exper...

IlluminOss Medical Inc.

IlluminOss Medical is a privately held, early-stage medical device company dedicated to the development of minimally invasive orthopedic systems for the stabilization and treatment of bone fractures. The IlluminOss Photodynamic Bone Stabilization System utilizes a photodynamic (light-curable) polymer system intended to eliminate the need for traditional, inconvenient and painful methods of bone f...

Vivus

VIVUS, Inc. is a pharmaceutical company dedicated to the development and commercialization of next-generation therapeutic products addressing obesity and sexual health. Analysts speculate that the potential market for obesity ranges from $5 billion to $10 billion annually, and the indications targeted by VIVUS' sexual health products each represent a projected market greater than $1 billion annual...

Millenium Biologix Incorporated

Millenium Biologix Inc. is a medical biotechnology company specializing in the commercialization of innovative products based on a proprietary synthetic bone technology. These advanced BioBone products are aimed at rapidly growing health care markets for the research, diagnosis and treatment of bone diseases.Millenium's area of expertise is the development and application of artificial bone biomat...

BioCoral Incorporated

Biocoral Inc. is an international company specializing in research & development and commercialization of biomaterials, biomedical technologies and biotechnologies.Via its subsidiary «INOTEB», the company researches, develops, manufactures and markets bone graft (Biocoral®) and other bone growth products for orthopedic, oral and maxillofacial applications to a number of countries outsid...

Osteologix Inc.

Osteologix develops proprietary therapeutics for the treatment of unmet medical needs in bone disease and women's health. The Company's lead product, NB S101, is being evaluated in a phase II clinical trial for the treatment of osteoporosis. Based on the Company's own data as well as data from phase III clinical trials conducted on a similar drug that is a...

Bone Biologics Corp.

Bone Biologics (OTCQB:BBLG) was founded to pursue regenerative medicine for bone.

SkeleTech, Inc.

SkeleTech is a therapeutically focused contract research organization providing pre-clinical discovery and development services in Bone and Central Nervous System (CNS) biologies.The Company's wide range of capabilities reflects years of experience in the study of human bone and CNS disorders. This experience enables SkeleTech to offer a wide range of scientific and technical expertise in model d...

Velcura Therapeutics, Inc.

Velcura Therapeutics, Inc. is an early stage biotechnology company headquartered in Ann Arbor, Michigan. Velcura's research focus is to understand human bone disease and to discover novel therapeutics that restore bone health. Velcura develops highly differentiated therapies for bone disease; specifically, therapies that restore the balance between bone building and bone loss activities in a s...

Cell Medica Limited

Cell Medica is a cellular therapeutics company engaged in the development, manufacturing and marketing of T cell immunotherapy approaches for the treatment of infections and cancers related to oncogenic viruses. The Company’s lead cell product, CytovirTM CMV, for the treatment and prevention of cytomegalovirus (CMV) infections in patients following al...

Artecef BV.

Malaria has become one of the world’s most devastating problems. The disease accounts for 1.5 to 2.7 millions deaths, of which about 1.0 million are African children, each year.Our mission is to cure people suffering from malaria and to become a centre of knowledge, research, development, sales and distribution of medication for the treatment of malaria, either curative or prophylactic.

Osteologix, Inc.

Osteologix is a specialty pharmaceutical company committed to developing innovative therapies for the treatment and prevention of diseases of bone and joint tissues. Its lead product candidate, NB S101, is a novel pharmaceutical agent for the treatment and prevention of osteoporosis. Osteologix has completed a Phase II clinical trial of NB S101 that ...

Gift of Life Bone Marrow Foundation

Gift of Life Bone Marrow Foundation is a 501(c)(3) non-profit organization dedicated to saving lives and facilitating bone marrow and blood stem cell transplants for patients with leukemia, lymphoma and other blood-related diseases. Ranking among the top international bone marrow registries, Gift of Life’s vision is to find A match. Anytime. An...

Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

ZYPPAH, Inc.

Zyppah hybrid oral appliances provide a revolutionary treatment for snoring and mild to moderate sleep apnea. Dr. Jonathan Greenburg, founder and CEO, has focused exclusively on sleep apnea and snoring since 2001 and has treated thousands of patients in his treatment centers since 2005.

Nucletron B.V.

Nucletron is a radiotherapy company that specializes in the development, manufacture, sales, service and support of the world's most innovative products for cancer treatment. As a company, our guiding principle is the customer's demand for quality, safety and reliability. We continuously invest in innovative research and development. This approach has made it possible to successfully treat cancers...

Cardion

CARDION AG, headquartered in Erkrath, Germany, with operations in Boston (USA), is a uniquely positioned biopharmaceutical company focusing on the development of innovative therapeutics for use in the curative treatment of heart and inflammatory diseases. CARDION currently focuses on three highly attractive product areas: • Arthritis/Inflammatory Franchise• Cardiovascular Franchise• Integrat...

Bone Care International Incorporated

Bone Care is a leader in the discovery and development of improved vitamin D-hormone therapies for the treatment of secondary hyperparathyroidism and certain hyperproliferative diseases. D-hormones have a key role in the progression and management of secondary hyperparathyroidism in patient populations with kidney dysfunction, including kidney Dialysis, pre-dialysis, and certain osteoporosis pati...

WindMIL Therapeutics

When it comes to cell therapy – cell source matters. At WindMIL, we are harnessing the power of bone marrow derived lymphocytes (MILs™) to develop ground-breaking immunotherapies to treat cancer patients. The bone marrow is a natural reservoir of T cells with unique advantages including inherent tumor-specificity. We have perfected an efficient and ...


More From BioPortfolio on "ORN Study: Curative Treatment of Osteoradionecrosis (ORN) With Hybrid Bone Substitution"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks